Life sciences
Align capital investments with evolving R&D pipelines
Keep facility readiness aligned with product and manufacturing priorities while maintaining GMP compliance.
Current landscape
$150B+
in announced life sciences capital investments through 2030
15-30%
higher capital project throughput with integrated delivery
Solutions that we provide
Life sciences organizations must keep capital investments aligned with evolving R&D pipelines, changing capacity needs, and stringent regulatory requirements. Aurigo Primus helps teams prioritize the right facility investments, connect planning, funding, and execution in one AI-native system of action, and keep commissioning and qualification on schedule so facilities are ready when needed while maintaining the control required for regulated environments.
Primus Plan Overview
Primus Build Overview
Benefits
Align investments with commercialization timelines
Keep commissioning and qualification on track
Deliver compliant facilities with confidence
AI that learns from every project you deliver
Resources
Get in touch
Connect with us to scale up the potential of your programs



